Skip to main content
Top
Published in: Journal of Clinical Immunology 5/2008

01-09-2008

Histamine Release and Inflammatory Cell Infiltration in Airway Mucosa in Methylene Diphenyl Diisocyanate (MDI)-Induced Occupational Asthma

Authors: Gyu-Young Hur, Seung-Soo Sheen, Young-Mi Kang, Dong-Hee Koh, Han-Jung Park, Young-Min Ye, Hyun-ee Yim, Kyoo-Sang Kim, Hae-Sim Park

Published in: Journal of Clinical Immunology | Issue 5/2008

Login to get access

Abstract

Introduction

Although methylene diphenyl diisocyanate (MDI) is widely used in industries, there have been few studies of the pathogenic mechanisms of MDI-induced occupational asthma (MDI-OA).

Methods

We performed immunohistochemical analyses, measured inflammatory mediators and cytokines, and quantified histamine release (HR) from peripheral basophils in MDI-OA patients. Thirteen MDI-exposed workers (five MDI-OA, two MDI-induced esoinophilic bronchitis, and six asymptomatic exposed controls, AEC) were enrolled.

Results and Discussion

Immunochemical analyses indicated significantly increased anti-eosinophilic cationic protein-stained cells in MDI-OA patients as compared with controls (P < 0.05). Sputum eosinophil cationic protein levels were increased after MDI-specific inhalation challenge test in MDI-OA/EB patients (P < 0.02). Sputum eosinophil counts were highly correlated with IL-8 and MMP-9 levels (P < 0.05 and P < 0.01, respectively). Basophil HR was significantly increased in MDI-OA patients after stimulations with anti-IgG4 and MDI–human serum albumin conjugates (both P < 0.05). Eosinophil activation is a major feature of airway inflammation in MDI-OA patients. Increased HR by MDI may contribute to the pathogenic mechanisms of MDI-OA.
Literature
1.
go back to reference Mapp CE. Agents, old and new, causing occupational asthma. Occup Environ Med. 2001;58:290, 354–60.CrossRef Mapp CE. Agents, old and new, causing occupational asthma. Occup Environ Med. 2001;58:290, 354–60.CrossRef
2.
go back to reference Mapp CE, Boschetto P, Maestrelli P, Fabbri LM. Occupational asthma. Am J Respir Crit Care Med. 2005;172:280–305.PubMedCrossRef Mapp CE, Boschetto P, Maestrelli P, Fabbri LM. Occupational asthma. Am J Respir Crit Care Med. 2005;172:280–305.PubMedCrossRef
3.
go back to reference Baur X, Seemann U, Marczynski B, Chen Z, Raulf-Heimsoth M. Humoral and cellular immune responses in asthmatic isocyanate workers: report of two cases. Am J Ind Med. 1996;29:467–73.PubMedCrossRef Baur X, Seemann U, Marczynski B, Chen Z, Raulf-Heimsoth M. Humoral and cellular immune responses in asthmatic isocyanate workers: report of two cases. Am J Ind Med. 1996;29:467–73.PubMedCrossRef
4.
go back to reference Keskinen H, Tupasela O, Tiikkainen U, Nordman H. Experiences of specific IgE in asthma due to diisocyanates. Clin Allergy. 1988;18:597–604.PubMedCrossRef Keskinen H, Tupasela O, Tiikkainen U, Nordman H. Experiences of specific IgE in asthma due to diisocyanates. Clin Allergy. 1988;18:597–604.PubMedCrossRef
5.
go back to reference Liss GM, Bernstein DI, Moller DR, Gallagher JS, Stephenson RL, Bernstein IL. Pulmonary and immunologic evaluation of foundry workers exposed to methylene diphenyldiisocyanate (MDI). J Allergy Clin Immunol. 1988;82:55–61.PubMedCrossRef Liss GM, Bernstein DI, Moller DR, Gallagher JS, Stephenson RL, Bernstein IL. Pulmonary and immunologic evaluation of foundry workers exposed to methylene diphenyldiisocyanate (MDI). J Allergy Clin Immunol. 1988;82:55–61.PubMedCrossRef
6.
go back to reference Tee RD, Cullinan P, Welch J, Burge PS, Newman-Taylor AJ. Specific IgE to isocyanates: a useful diagnostic role in occupational asthma. J Allergy Clin Immunol. 1998;101:709–15.PubMedCrossRef Tee RD, Cullinan P, Welch J, Burge PS, Newman-Taylor AJ. Specific IgE to isocyanates: a useful diagnostic role in occupational asthma. J Allergy Clin Immunol. 1998;101:709–15.PubMedCrossRef
7.
go back to reference Hur GY, Koh DH, Choi GS, Park HJ, Choi SJ, Ye YM et al. Clinical and immunologic findings of methylene diphenyl diisocyanate induced occupational asthma in a car upholstery factory. Clin Exp Allergy. 2008; in press. Hur GY, Koh DH, Choi GS, Park HJ, Choi SJ, Ye YM et al. Clinical and immunologic findings of methylene diphenyl diisocyanate induced occupational asthma in a car upholstery factory. Clin Exp Allergy. 2008; in press.
8.
go back to reference Lee YM, Kim HA, Park HS, Lee SK, Nahm DH. Exposure to toluene diisocyanate (TDI) induces IL-8 production from bronchial epithelial cells: effect of pro-inflammatory cytokines. J Korean Med Sci. 2003;18:809–12.PubMed Lee YM, Kim HA, Park HS, Lee SK, Nahm DH. Exposure to toluene diisocyanate (TDI) induces IL-8 production from bronchial epithelial cells: effect of pro-inflammatory cytokines. J Korean Med Sci. 2003;18:809–12.PubMed
9.
go back to reference Park H, Jung K, Kim H, Nahm D, Kang K. Neutrophil activation following TDI bronchial challenges to the airway secretion from subjects with TDI-induced asthma. Clin Exp Allergy. 1999;29:1395–401.PubMedCrossRef Park H, Jung K, Kim H, Nahm D, Kang K. Neutrophil activation following TDI bronchial challenges to the airway secretion from subjects with TDI-induced asthma. Clin Exp Allergy. 1999;29:1395–401.PubMedCrossRef
10.
go back to reference Hur GY, Koh DH, Choi GS, Park HJ, Choi SJ, Ye YM, et al. Clinical and immunologic findings of methylene diphenyl diisocyanate induced occupational asthma in a car upholstery factory. Clin Exp Allergy 2008;38:586–93.PubMedCrossRef Hur GY, Koh DH, Choi GS, Park HJ, Choi SJ, Ye YM, et al. Clinical and immunologic findings of methylene diphenyl diisocyanate induced occupational asthma in a car upholstery factory. Clin Exp Allergy 2008;38:586–93.PubMedCrossRef
11.
go back to reference Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000;161:309–29.PubMed Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000;161:309–29.PubMed
12.
go back to reference Zammit-Tabona M, Sherkin M, Kijek K, Chan H, Chan-Yeung M. Asthma caused by diphenylmethane diisocyanate in foundry workers. Clinical, bronchial provocation, and immunologic studies. Am Rev Respir Dis. 1983;128:226–30.PubMed Zammit-Tabona M, Sherkin M, Kijek K, Chan H, Chan-Yeung M. Asthma caused by diphenylmethane diisocyanate in foundry workers. Clinical, bronchial provocation, and immunologic studies. Am Rev Respir Dis. 1983;128:226–30.PubMed
13.
go back to reference Jang AS, Choi IS, Park CS. Immunohistochemically stained activated eosinophils in sputum in patients with asthma. Respiration. 2000;67:183–8.PubMedCrossRef Jang AS, Choi IS, Park CS. Immunohistochemically stained activated eosinophils in sputum in patients with asthma. Respiration. 2000;67:183–8.PubMedCrossRef
14.
go back to reference Bae JS, Kim SH, Ye YM, Yoon HJ, Suh CH, Nahm DH, et al. Significant association of FcepsilonRIalpha promoter polymorphisms with aspirin-intolerant chronic urticaria. J Allergy Clin Immunol. 2007;119:449–56.PubMedCrossRef Bae JS, Kim SH, Ye YM, Yoon HJ, Suh CH, Nahm DH, et al. Significant association of FcepsilonRIalpha promoter polymorphisms with aspirin-intolerant chronic urticaria. J Allergy Clin Immunol. 2007;119:449–56.PubMedCrossRef
15.
go back to reference Vasagar K, Vonakis BM, Gober LM, Viksman A, Gibbons SP Jr, Saini SS. Evidence of in vivo basophil activation in chronic idiopathic urticaria. Clin Exp Allergy. 2006;36:770–6.PubMedCrossRef Vasagar K, Vonakis BM, Gober LM, Viksman A, Gibbons SP Jr, Saini SS. Evidence of in vivo basophil activation in chronic idiopathic urticaria. Clin Exp Allergy. 2006;36:770–6.PubMedCrossRef
16.
go back to reference Tong LJ, Balakrishnan G, Kochan JP, Kinet JP, Kaplan AP. Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol. 1997;99:461–5.PubMedCrossRef Tong LJ, Balakrishnan G, Kochan JP, Kinet JP, Kaplan AP. Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol. 1997;99:461–5.PubMedCrossRef
17.
go back to reference Jarjour NN, Sedgwick JB, Swensen CA, Busse WW. Late allergic airway response to segmental bronchopulmonary provocation in allergic subjects is related to peripheral blood basophil histamine release. J Allergy Clin Immunol. 1997;99:87–93.PubMed Jarjour NN, Sedgwick JB, Swensen CA, Busse WW. Late allergic airway response to segmental bronchopulmonary provocation in allergic subjects is related to peripheral blood basophil histamine release. J Allergy Clin Immunol. 1997;99:87–93.PubMed
18.
go back to reference Saetta M, Di Stefano A, Maestrelli P, De Marzo N, Milani GF, Pivirotto F, et al. Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate. Am Rev Respir Dis. 1992;145:160–8.PubMed Saetta M, Di Stefano A, Maestrelli P, De Marzo N, Milani GF, Pivirotto F, et al. Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate. Am Rev Respir Dis. 1992;145:160–8.PubMed
19.
go back to reference Di Stefano A, Saetta M, Maestrelli P, Milani G, Pivirotto F, Mapp CE, et al. Mast cells in the airway mucosa and rapid development of occupational asthma induced by toluene diisocyanate. Am Rev Respir Dis. 1993;147:1005–9.PubMed Di Stefano A, Saetta M, Maestrelli P, Milani G, Pivirotto F, Mapp CE, et al. Mast cells in the airway mucosa and rapid development of occupational asthma induced by toluene diisocyanate. Am Rev Respir Dis. 1993;147:1005–9.PubMed
20.
go back to reference Park HS, Hwang SC, Nahm DH, Yim HE. Immunohistochemical characterization of the cellular infiltrate in airway mucosa of toluene diisocyanate (TDI)-induced asthma: comparison with allergic asthma. J Korean Med Sci. 1998;13:21–6.PubMed Park HS, Hwang SC, Nahm DH, Yim HE. Immunohistochemical characterization of the cellular infiltrate in airway mucosa of toluene diisocyanate (TDI)-induced asthma: comparison with allergic asthma. J Korean Med Sci. 1998;13:21–6.PubMed
21.
go back to reference Sun LZ, Elsayed S, Bronstad AM, Van Do T, Irgens A, Aardal NP, et al. Airway inflammation and bronchial remodelling in toluene diisocyanate-exposed BALB/c mouse model. Scand J Immunol. 2007;65:118–25.PubMedCrossRef Sun LZ, Elsayed S, Bronstad AM, Van Do T, Irgens A, Aardal NP, et al. Airway inflammation and bronchial remodelling in toluene diisocyanate-exposed BALB/c mouse model. Scand J Immunol. 2007;65:118–25.PubMedCrossRef
22.
go back to reference Mapp CE, Lapa e Silva JR, Lucchini RE, Chitano P, Rado V, Saetta M, et al. Inflammatory events in the blood and airways of guinea pigs immunized to toluene diisocyanate. Am J Respir Crit Care Med. 1996;154:201–8.PubMed Mapp CE, Lapa e Silva JR, Lucchini RE, Chitano P, Rado V, Saetta M, et al. Inflammatory events in the blood and airways of guinea pigs immunized to toluene diisocyanate. Am J Respir Crit Care Med. 1996;154:201–8.PubMed
23.
go back to reference Bentley AM, Maestrelli P, Saetta M, Fabbri LM, Robinson DS, Bradley BL, et al. Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. J Allergy Clin Immunol. 1992;89:821–9.PubMedCrossRef Bentley AM, Maestrelli P, Saetta M, Fabbri LM, Robinson DS, Bradley BL, et al. Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. J Allergy Clin Immunol. 1992;89:821–9.PubMedCrossRef
24.
go back to reference Shakoory B, Fitzgerald SM, Lee SA, Chi DS, Krishnaswamy G. The role of human mast cell-derived cytokines in eosinophil biology. J Interferon Cytokine Res. 2004;24:271–81.PubMedCrossRef Shakoory B, Fitzgerald SM, Lee SA, Chi DS, Krishnaswamy G. The role of human mast cell-derived cytokines in eosinophil biology. J Interferon Cytokine Res. 2004;24:271–81.PubMedCrossRef
25.
go back to reference Matheson JM, Johnson VJ, Luster MI. Immune mediators in a murine model for occupational asthma: studies with toluene diisocyanate. Toxicol Sci. 2005;84:99–109.PubMedCrossRef Matheson JM, Johnson VJ, Luster MI. Immune mediators in a murine model for occupational asthma: studies with toluene diisocyanate. Toxicol Sci. 2005;84:99–109.PubMedCrossRef
26.
go back to reference Maestrelli P, Occari P, Turato G, Papiris SA, Di Stefano A, Mapp CE, et al. Expression of interleukin (IL)-4 and IL-5 proteins in asthma induced by toluene diisocyanate (TDI). Clin Exp Allergy. 1997;27:1292–8.PubMedCrossRef Maestrelli P, Occari P, Turato G, Papiris SA, Di Stefano A, Mapp CE, et al. Expression of interleukin (IL)-4 and IL-5 proteins in asthma induced by toluene diisocyanate (TDI). Clin Exp Allergy. 1997;27:1292–8.PubMedCrossRef
27.
go back to reference Yuo A, Kitagawa S, Kasahara T, Matsushima K, Saito M, Takaku F. Stimulation and priming of human neutrophils by interleukin-8: cooperation with tumor necrosis factor and colony-stimulating factors. Blood. 1991;78:2708–14.PubMed Yuo A, Kitagawa S, Kasahara T, Matsushima K, Saito M, Takaku F. Stimulation and priming of human neutrophils by interleukin-8: cooperation with tumor necrosis factor and colony-stimulating factors. Blood. 1991;78:2708–14.PubMed
28.
29.
go back to reference Atkinson JJ, Senior RM. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol. 2003;28:12–24.PubMedCrossRef Atkinson JJ, Senior RM. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol. 2003;28:12–24.PubMedCrossRef
30.
go back to reference Chiappara G, Gagliardo R, Siena A, Bonsignore MR, Bousquet J, Bonsignore G, et al. Airway remodelling in the pathogenesis of asthma. Curr Opin Allergy Clin Immunol. 2001;1:85–93.PubMed Chiappara G, Gagliardo R, Siena A, Bonsignore MR, Bousquet J, Bonsignore G, et al. Airway remodelling in the pathogenesis of asthma. Curr Opin Allergy Clin Immunol. 2001;1:85–93.PubMed
31.
go back to reference Stahle-Backdahl M, Parks WC. 92-Kd gelatinase is actively expressed by eosinophils and stored by neutrophils in squamous cell carcinoma. Am J Pathol. 1993;142:995–1000.PubMed Stahle-Backdahl M, Parks WC. 92-Kd gelatinase is actively expressed by eosinophils and stored by neutrophils in squamous cell carcinoma. Am J Pathol. 1993;142:995–1000.PubMed
32.
go back to reference Cataldo DD, Bettiol J, Noel A, Bartsch P, Foidart JM, Louis R. Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge. Chest. 2002;122:1553–9.PubMedCrossRef Cataldo DD, Bettiol J, Noel A, Bartsch P, Foidart JM, Louis R. Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge. Chest. 2002;122:1553–9.PubMedCrossRef
33.
go back to reference Schwingshackl A, Duszyk M, Brown N, Moqbel R. Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-alpha. J Allergy Clin Immunol. 1999;104:983–9.PubMedCrossRef Schwingshackl A, Duszyk M, Brown N, Moqbel R. Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-alpha. J Allergy Clin Immunol. 1999;104:983–9.PubMedCrossRef
34.
go back to reference Park HS, Kim HA, Jung JW, Kim YK, Lee SK, Kim SS, et al. Metalloproteinase-9 is increased after toluene diisocyanate exposure in the induced sputum from patients with toluene diisocyanate-induced asthma. Clin Exp Allergy. 2003;33:113–8.PubMedCrossRef Park HS, Kim HA, Jung JW, Kim YK, Lee SK, Kim SS, et al. Metalloproteinase-9 is increased after toluene diisocyanate exposure in the induced sputum from patients with toluene diisocyanate-induced asthma. Clin Exp Allergy. 2003;33:113–8.PubMedCrossRef
35.
go back to reference Puxeddu I, Ribatti D, Crivellato E, Levi-Schaffer F. Mast cells and eosinophils: a novel link between inflammation and angiogenesis in allergic diseases. J Allergy Clin Immunol. 2005;116:531–6.PubMedCrossRef Puxeddu I, Ribatti D, Crivellato E, Levi-Schaffer F. Mast cells and eosinophils: a novel link between inflammation and angiogenesis in allergic diseases. J Allergy Clin Immunol. 2005;116:531–6.PubMedCrossRef
36.
go back to reference Lee CG, Link H, Baluk P, Homer RJ, Chapoval S, Bhandari V, et al. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med. 2004;10:1095–103.PubMedCrossRef Lee CG, Link H, Baluk P, Homer RJ, Chapoval S, Bhandari V, et al. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med. 2004;10:1095–103.PubMedCrossRef
37.
go back to reference Asai K, Kanazawa H, Kamoi H, Shiraishi S, Hirata K, Yoshikawa J. Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients. Clin Exp Allergy. 2003;33:595–9.PubMedCrossRef Asai K, Kanazawa H, Kamoi H, Shiraishi S, Hirata K, Yoshikawa J. Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients. Clin Exp Allergy. 2003;33:595–9.PubMedCrossRef
38.
go back to reference Choi JH, Suh YJ, Lee SK, Suh CH, Nahm DH, Park HS. Acute and chronic changes of vascular endothelial growth factor (VEGF) in induced sputum of toluene diisocyanate (TDI)-induced asthma patients. J Korean Med Sci. 2004;19:359–63.PubMedCrossRef Choi JH, Suh YJ, Lee SK, Suh CH, Nahm DH, Park HS. Acute and chronic changes of vascular endothelial growth factor (VEGF) in induced sputum of toluene diisocyanate (TDI)-induced asthma patients. J Korean Med Sci. 2004;19:359–63.PubMedCrossRef
39.
go back to reference Lummus ZL, Alam R, Bernstein JA, Bernstein DI. Characterization of histamine releasing factors in diisocyanate-induced occupational asthma. Toxicology. 1996;111:191–206.PubMedCrossRef Lummus ZL, Alam R, Bernstein JA, Bernstein DI. Characterization of histamine releasing factors in diisocyanate-induced occupational asthma. Toxicology. 1996;111:191–206.PubMedCrossRef
40.
go back to reference Kivity S, Veintrov V, Fireman E, Agami O, Lerman Y. The in vivo effect of isocyanate-induced asthma on basophil histamine release. Allergy. 1998;53:407–10.PubMedCrossRef Kivity S, Veintrov V, Fireman E, Agami O, Lerman Y. The in vivo effect of isocyanate-induced asthma on basophil histamine release. Allergy. 1998;53:407–10.PubMedCrossRef
Metadata
Title
Histamine Release and Inflammatory Cell Infiltration in Airway Mucosa in Methylene Diphenyl Diisocyanate (MDI)-Induced Occupational Asthma
Authors
Gyu-Young Hur
Seung-Soo Sheen
Young-Mi Kang
Dong-Hee Koh
Han-Jung Park
Young-Min Ye
Hyun-ee Yim
Kyoo-Sang Kim
Hae-Sim Park
Publication date
01-09-2008
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 5/2008
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-008-9199-y

Other articles of this Issue 5/2008

Journal of Clinical Immunology 5/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.